The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK.
University of California San Francisco, San Francisco, California, USA.
Clin Oncol (R Coll Radiol). 2020 Mar;32(3):189-198. doi: 10.1016/j.clon.2019.12.007. Epub 2020 Jan 21.
Recent studies assessing the patterns of failure following locoregional definitive therapy suggest that recurrences do happen in the adjacent most proximal drainage sites, not infrequently occurring within the common iliac and para-aortic regions. This pattern of recurrence and identification at initial presentation is being increasingly recognised using novel imaging techniques and there is limited evidence on how to manage these patients. We are awaiting definitive evidence regarding the clinical benefit of whole pelvic radiotherapy, and currently there is no consensus as to the optimal superior border. There is some acknowledgement that the superior border should encompass the common iliac nodal region. However, whether it should be extended even more proximally is currently unknown. Prospective randomised trials are required to determine if there is a role for extending the radiotherapy field in patients with or at high risk of para-aortic metastases.
最近的研究评估了局部区域根治性治疗后失败的模式,表明复发确实发生在相邻的最近端引流部位,并不罕见地发生在髂总和腹主动脉旁区域。这种复发模式和初始表现的识别正越来越多地通过新的成像技术来实现,而对于如何管理这些患者,证据有限。我们正在等待关于全骨盆放疗的临床获益的明确证据,目前对于最佳上界还没有共识。人们已经认识到上界应包括髂淋巴结区域。然而,是否应该更向近端延伸目前尚不清楚。需要前瞻性随机试验来确定对于有或高风险发生腹主动脉旁转移的患者,是否有必要扩大放疗范围。